Cystic fibrosis transmembrane conductance regulator biomarkers in `real life´ : can we evaluate individual efficacy of cystic fibrosis transmembrane conductance regulator therapy?
| dc.contributor.author | Koningsbruggen-Rietschel, Silke van | |
| dc.contributor.author | Nährlich, Lutz | |
| dc.date.accessioned | 2023-06-02T13:37:36Z | |
| dc.date.available | 2017-01-13T14:04:05Z | |
| dc.date.available | 2023-06-02T13:37:36Z | |
| dc.date.issued | 2015 | |
| dc.identifier.uri | http://nbn-resolving.de/urn:nbn:de:hebis:26-opus-124433 | |
| dc.identifier.uri | https://jlupub.ub.uni-giessen.de//handle/jlupub/16359 | |
| dc.identifier.uri | http://dx.doi.org/10.22029/jlupub-15739 | |
| dc.language.iso | en | de_DE |
| dc.rights | In Copyright | * |
| dc.rights.uri | http://rightsstatements.org/page/InC/1.0/ | * |
| dc.subject.ddc | ddc:610 | de_DE |
| dc.title | Cystic fibrosis transmembrane conductance regulator biomarkers in `real life´ : can we evaluate individual efficacy of cystic fibrosis transmembrane conductance regulator therapy? | de_DE |
| dc.type | article | de_DE |
| local.affiliation | FB 11 - Medizin | de_DE |
| local.comment | Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG geförderten) Allianz- bzw. Nationallizenz frei zugänglich. This publication is with permission of the rights owner freely accessible due to an Alliance licence and a national licence (funded by the DFG, German Research Foundation) respectively. | |
| local.opus.fachgebiet | Medizin | de_DE |
| local.opus.id | 12443 | |
| local.opus.institute | Department of Pediatrics | de_DE |
| local.source.freetext | Therapeutic Advances in Respiratory Disease 9(4): 198-200, DOI: 10.1177/ 1753465815579364 | de_DE |
| local.source.uri | https://doi.org/10.1177/1753465815579364 |
Dateien
Originalbündel
1 - 1 von 1